Format

Send to

Choose Destination
Elife. 2016 Oct 26;5. pii: e19374. doi: 10.7554/eLife.19374.

Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons.

Author information

1
Department of Neurophysiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
2
NeuroCure Cluster of Excellence, Charité Universitätsmedizin Berlin, Berlin, Germany.
3
Institute of Biochemistry, Charité Universitätsmedizin Berlin, Berlin, Germany.

Abstract

Mutations in the MECP2 gene cause the neurodevelopmental disorder Rett syndrome (RTT). Previous studies have shown that altered MeCP2 levels result in aberrant neurite outgrowth and glutamatergic synapse formation. However, causal molecular mechanisms are not well understood since MeCP2 is known to regulate transcription of a wide range of target genes. Here, we describe a key role for a constitutive BDNF feed forward signaling pathway in regulating synaptic response, general growth and differentiation of glutamatergic neurons. Chronic block of TrkB receptors mimics the MeCP2 deficiency in wildtype glutamatergic neurons, while re-expression of BDNF quantitatively rescues MeCP2 deficiency. We show that BDNF acts cell autonomous and autocrine, as wildtype neurons are not capable of rescuing growth deficits in neighboring MeCP2 deficient neurons in vitro and in vivo. These findings are relevant for understanding RTT pathophysiology, wherein wildtype and mutant neurons are intermixed throughout the nervous system.

KEYWORDS:

BDNF; Rett syndrome; cell autonomous; glutamatergic; mouse; neuroscience; synaptic transmission

PMID:
27782879
PMCID:
PMC5108590
DOI:
10.7554/eLife.19374
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for eLife Sciences Publications, Ltd Icon for PubMed Central
Loading ...
Support Center